Celregen Therapeutics
PrivateLast Round
VC Round
Mar 19, 2025
Total Funding Raised
$6.67M
Company Overview
Celregen Therapeutics is a biotechnology company that focuses on the development of novel medications in the domains of cell therapy and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celregen Therapeutics Comparables
Compare Celregen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neukio Biotherapeutics | 83% | |
| Nuwacell Biotechnologies Co., Ltd. | 83% | |
| Cellusion Inc. | 81% |
Celregen Therapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2025
$14M raised in a VC Round.
- Aug 8, 2022
Raised $7M in Seed funding
Celregen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Celregen Therapeutics's valuation, stock price, and market status.
Is Celregen Therapeutics a public or private company?
Celregen Therapeutics is a private company.
What is the current stock price of Celregen Therapeutics?
Celregen Therapeutics is a private company, so its shares have no public market price. Caplight tracks Celregen Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celregen Therapeutics worth (valuation)?
Valuation information for Celregen Therapeutics is not publicly available.
Can I buy Celregen Therapeutics stock?
Celregen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celregen Therapeutics's last funding round?
Celregen Therapeutics's most recent funding round was VC Round on March 19, 2025.
Who are the main investors in Celregen Therapeutics?
Investor information for Celregen Therapeutics is not publicly disclosed.
Will Celregen Therapeutics IPO soon?
No public IPO plans have been announced for Celregen Therapeutics.
How can I track Celregen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Celregen Therapeutics's shares on secondary markets.